Vivex Biologics, Inc.August 4, 2022

FDA 483 - Vivex Biologics, Inc. - August 04, 2022

FDA 483 for Vivex Biologics, Inc. on August 04, 2022. Product: biologics. Access full analysis and detailed observations.

View on Dashboard

One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.

Record Summary

FDA 483 for Vivex Biologics, Inc. on August 04, 2022. Product: biologics. Access full analysis and detailed observations.

Get More Insights

Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.

1.5M+ regulatory data points

Real-time compliance monitoring

Interactive analytics dashboard

Looking for more records? Our platform provides access to thousands of similar regulatory documents with advanced search and filtering capabilities.

Record Information

Company

Vivex Biologics, Inc.

Inspection Date

August 4, 2022

Product Type

biologics

Office

Office of Medical Device and Radiological Health Division II

People

ID: 05124755-0e64-439b-8c93-0281e4ed854b

View on Dashboard

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.

Try KeyPedia Today

Explore our real use cases and discover our features in depth.

Subscribe to our newsletter

Get the latest updates and insights delivered to your inbox